4
,2!'"1 +E J MP !? !-,2',',% ,2!'"1 2SKQ +??JMV & 2 RAs $?KMRGBGLC ,GX?RGBGLC 0?LGRGBGLC .0-2-, .3+. ',&''2-01 ..' #QMKCNP?XMJC *?LQMNP?XMJC -KCNP?XMJC .?LRMNP?XMJC 0?@CNP?XMJC ',2#%01# ',&''2-01 "-*32#%04'0 (Tivicay, Triumeq) η #NKTSDFQ@UHQ Ȗ Ȗ f #*4'2#%04'0!-'!'122 1RPG@GJB %CLTMW? η $KUHSDFQ@UHQ Ȗ Ȗ f 0*2#%04'0 'QCLRPCQQ X 1@KSDFQ@UHQ Ȗ Ȗ .0-2#1# ',&''2-01 0'2-,4'0 (Norvir) or AM@GAGQR?R@MMQRCB .'Q CE f 28,4'0 (Evotaz, Reyataz) η S@Y@M@UHQ η S@Y@M@UHQ η S@Y@M@UHQ VHSG KNV CNRD //( X S@Y@M@UHQ VHSG GHFG //( f "03,4'0 .PCXAM@GV .PCXGQR? f *-.',4'0 Kaletra Ȗ Ȗ Ȗ !'" 13..0#11',% "03%1 !'" 13..0#11',% "03%1

DDI tool English final · K@W@SHUDR ÓRTBQ@KE@SD ÓNQ@KÓHQNM ... DDI tool_English_final.pdf Author: t41nspm Created Date: 8/8/2016 3:19:04 PM

Embed Size (px)

Citation preview

2RAs

• (Tivicay, Triumeq)

X

(Norvir) or

(Evotaz, Reyataz)

X

Kaletra

2RAs

• X

• (Viramune)

2RAs

chelation leading to poor absorption

increase in gastric pH leads

to poor absorption

increase in gastric pH leads to poor absorption

increase in gastric pH leads

to poor absorption

increase in gastric pH leads to poor absorption

increase in gastric pH leads to poor absorption

MANAGEMENT

Administer

or calcium supplements and

taken at same time as calcium and iron supplements

containing antacids

may be coadministered

Administer antacids

2

Coadministration is not recommended

or comparable

No dose adjustment required.

Use combination with caution. Adjustment in drug dose or frequency, additional/more frequent monitoring, or use of an alternative agent may be required. May wish to consult with a pharmacist knowledgeable in HIV drug interactions.

X Contraindicated/avoid combination.

H VA MANAGEMENT TOOL FOR

© 2016 The Canadian HIV/AIDS Pharmacists Network (CHAP)

All listed brands are trademarks or registered trademarks of

their respective owners.

Printed with the assistance of an unrestricted

educational grant from: